SCHOLAR ROCK HOLDING CORPORATION

SRRK ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $0 $33.2M $18.8M $15.4M $20.5M $0
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $208.4M $124.4M $108.5M $74.1M $54.2M $36.3M
SG&A Expense $176.2M $43.1M $40.3M $28.2M $20.8M $14.4M
Operating Income $-384.6M $-134.4M $-129.9M $-86.9M $-54.5M $-50.7M
Operating Margin -404.8% -690.5% -564.0% -266.2%
Interest Expense $6.3M $4.7M $2.1M $400.0K $27.0K
Pretax Income
Income Tax Expense
Net Income $-377.9M $-134.5M $-131.8M $-86.5M $-51.0M $-49.3M
Net Margin -405.2% -700.5% -561.5% -248.9%
EPS (Basic) $-3.29 $-2.26 $-3.59 $-2.81 $-1.85 $-3.15
EPS (Diluted) $-3.29 $-2.26 $-3.59 $-2.81 $-1.85 $-3.15
Shares Outstanding (Basic) 114.7M 59.6M 36.7M 30.7M 29.8M 26.2M
Shares Outstanding (Diluted) 114.7M 59.6M 36.7M 30.7M 29.8M 26.2M
Dividends Per Share